Clinical Trial Update: Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations [Phase 2, Phase 3]

View source ↗

Summary

A double-blind trial of everolimus to improve social abilities in individuals with PTEN germline mutations. The study includes Cowden syndrome and related PTEN …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bannayan-riley-ruvalcaba Syndrome
• Cowden Syndrome
• Lhermitte-duclos Disease
• Pten Hamartoma Tumor Syndrome

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Cowden's Disease, Cowden's Syndrome | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING